Baird initiated coverage of Beta Bionics (BBNX) with a Neutral rating and $20 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.